Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Kristin Morris"'
Autor:
Christopher J Nirschl, Kyriakos Economides, Kristin Morris, Andres Salmeron, Daniel J Hicklin, Cynthia Seidel-Dugan, Kulandayan K Subramanian, Randi Isaacs, Sameer Chopra, Celesztina Domonkos
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/cf1f1cc9b0be40e987cd30bbaf33f839
252 The combination of ACT and INDUKINE therapy leads to improved antitumor immunity in solid tumors
Autor:
Kyriakos Economides, Kristin Morris, Andres Salmeron, Connor J Dwyer, Heather R Brodkin, Daniel J Hicklin, Cynthia Seidel-Dugan, William M Winston, Olivia G Donovan, Julie LePrevost
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2f1f22f5f1b0489b8bac8a7f7313a641
Autor:
Brendan Curti, Igor Puzanov, Mateusz Opyrchal, Christopher J Nirschl, Mehmet A Bilen, Kristin Morris, Justin C Moser, Ildefonso Rodriguez Rivera, Saero Park, Marissa Bruno, Paul Windt, Kulandayan K Subramanian, Sameer S Chopra, Randi Isaacs
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2c535f528fe849388924b327f27fc65e
Autor:
Christopher Nirschl, Kristin Morris, Heather Brodkin, Daniel Hicklin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d86897847aaf419eb3bd1dfc53e9e0d2
Autor:
Christopher Nirschl, Kristin Morris, Heather Brodkin, Daniel Hicklin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston, Cindy Seidel-Dugan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/3596c09c2f37405a823df42493709240
Autor:
Christopher Nirschl, Kristin Morris, Heather Brodkin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston, Cindy Seidel-Dugan, Ethika Tyagi, Josue Canales, Dan Hicklin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/18dad127330e419b9eb3381e399e2e74
Autor:
Andres Salmeron, William M. Winston, Ethika Tyagi, Jenna M. Sullivan, Zoe Steuert, Philipp Steiner, Cynthia Seidel-Dugan, Kristin Morris, Nesreen Ismail, Daniel J. Hicklin, Heather R. Brodkin, Christopher J. Nirschl
Supplementary Figure from Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cfb7df63e698ef8b4821edab904947
https://doi.org/10.1158/2326-6066.22544463
https://doi.org/10.1158/2326-6066.22544463
Autor:
Andres Salmeron, William M. Winston, Ethika Tyagi, Jenna M. Sullivan, Zoe Steuert, Philipp Steiner, Cynthia Seidel-Dugan, Kristin Morris, Nesreen Ismail, Daniel J. Hicklin, Heather R. Brodkin, Christopher J. Nirschl
IL-2 is a cytokine clinically approved for the treatment of melanoma and renal cell carcinoma. Unfortunately, its clinical utility is hindered by serious side effects driven by the systemic activity of the cytokine. Here, we describe the design and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2168b0d31bbc750666d6eb61ea5fc054
https://doi.org/10.1158/2326-6066.c.6550650
https://doi.org/10.1158/2326-6066.c.6550650
Autor:
Heather Brodkin, Kristin Morris, William Winston, Philipp Steiner, Nesreen Ismail, Christopher J. Nirschl, Daniel J. Hicklin, Andres Salmeron, Jenna Sullivan, Zoe Steuert
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundSystemic administration of proinflammatory cytokines is a promising approach to treat cancer. However, poor pharmacokinetic properties and dose-limiting toxicities after systemic administration of cytokines such as interleukin 12 (IL-12) re
Autor:
Zoe Steuert, Christopher J. Nirschl, Jenna Sullivan, Ethika Tyagi, Cindy Seidel-Dugan, Philipp Steiner, Dan Hicklin, William Winston, Heather Brodkin, Nesreen Ismail, Josue Canales, Kristin Morris, Andres Salmeron
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundInterferon α (IFNα) was the first cytokine clinically tested as a cancer therapy. IFNα is a member of the type-I IFN family and activates immune responses either directly by engaging IFNα receptors (IFNAR) ubiquitously expressed on immu